Focusing on cell lines with heterozygous mutations, we found that six pan-cancer missense mutational cancer genes (TP53, KRAS, BRAF, CTNNB1, PIK3CA and LRP1B) remained significant hits when we only considered cell lines with homozygous deletions. The gene discussed is KRAS; the disease is cancer.